Overview

Advancing Stroke Safety and Efficacy Through Early Tirofiban Administration After Intravenous Thrombolysis (ASSET-IT)

Status:
Not yet recruiting
Trial end date:
2027-06-30
Target enrollment:
Participant gender:
Summary
To assess the efficacy and safety of tirofiban administration after intravenous thrombolysis for patients with AIS.
Phase:
Phase 3
Details
Lead Sponsor:
The First Affiliated Hospital of University of Science and Technology of China
Treatments:
Tirofiban